Cel Sci Corporation (CVM)

[rwa3848]

Why are you pushing the narrative that employees will be spending money? We are dealing with the market situation for CVM. Employees have not exercised their options prior to data release and are unlikely to risk their money on uncertain results. If data is good, the company will be bought out + cash. If data is bad, options will be worthless. There is only one condition where the price of options is relevant to employees and that condition is if the phase III data is perfectly in the middle of expectations so as to somehow keep the share price from immediately collapsing below the cost of the cheapest options & remaining moribund until an inevitable buyout coinciding with the FDA drug approval panel recommendation.